ABCB10 and lung carcinoma: As illustrated in Fig. 1e, in comparison with that in control cells, the expression of circ-ABCB10 was significantly declined in cisplatin-treated cells rather than other drugs including 5-FU, Sorafenib, and Sunitinib, indicating that circ-ABCB10 was related to cellular response to cisplatin in lung cancer.